Used in pharmaceutical synthesis as a protected amine intermediate, particularly in the development of bioactive molecules requiring selective amine functionalization. Its structure supports conformational restriction, making it valuable in medicinal chemistry for optimizing receptor binding and metabolic stability. Commonly employed in the preparation of central nervous system agents and enzyme inhibitors where cyclobutane-based scaffolds enhance potency and selectivity.